On May 23, the 2022 “Drug Science and Technology Activity Week” hosted by the State Drug Administration and jointly organized by the Chinese Pharmaceutical Association, the China National Institute for Food and Drug Control, the Medical Device Technology Review Center of the State Food and Drug Administration, and China Health Media Group The launching ceremony and the Regulatory Science Forum were held online, and the whole process was broadcast live to the society. Zhao Junning, deputy director of the State Drug Administration, attended and delivered a speech.
The Science and Technology Week is a nationwide mass science and technology activity approved by the State Council. It has been held in the third week of May every year since 2001. Since 2015, the national drug regulatory department has held the national drug regulatory system science and technology week activities at the same time every year, to publicize the drug regulatory reform and scientific and technological innovation achievements to the society, and popularize the knowledge of drug safety. The theme of this year’s “Drug Science and Technology Week” is “Supervision Science, You and I Walk Together”.
Zhao Junning pointed out that drug safety is directly related to the health and life safety of the people, and the development of regulatory science is of great significance to improving regulatory efficiency, creating a strong industry and protecting people’s health. Under the strong leadership of the CPC Central Committee with Comrade Xi Jinping at its core, the State Food and Drug Administration resolutely implements the decisions and arrangements of the CPC Central Committee and the State Council, adheres to the principle of putting people first and life first, always puts people’s safety and health first, and actively promotes medicines. , vaccine, medical device scientific and technological breakthroughs, fully promote emergency review and approval, and effectively serve the overall situation of epidemic prevention and control. Drug regulatory authorities at all levels must fulfill their regulatory mission, continuously innovate regulatory methods and methods, strengthen scientific research on drug regulatory research and the application of results, support drug and medical device research and development, and assist in anti-epidemic and drug safety; closely follow international frontiers and further promote drug regulation Scientific research will promote more results; it is necessary to strengthen investment in science and technology, use regulatory science to boost and lead the high-quality development of the traditional Chinese medicine industry, and inherit, develop and utilize the precious wealth of traditional Chinese medicine.
Zhao Junning emphasized that holding a drug science and technology activity week is an important way to popularize and popularize the results of drug supervision work. All localities should solidly promote the popularization of drug safety science and improve the public’s awareness of drug safety; vigorously carry out scientific and technological popularization and multi-level scientific and technological training, fully display the scientific research results of drug supervision, and protect and promote public health.
The “Regulatory Science Forum” was held following the launching ceremony. Academicians Wang Chen and Wang Junzhi of the Chinese Academy of Engineering started from their respective research fields and delivered keynote speeches on regulatory science. The main person in charge of the Science and Technology and International Cooperation Department of the State Drug Administration introduced the work of regulatory science to help the innovation and development of drug supervision, and the relevant person in charge of the organizer made a keynote speech.
